Published Version
Open DOI LinkAbstract
BackgroundClinical evidence points to an increased risk of renal comorbidity in ankylosing spondylitis (AS) compared to the general population. However, there are no population-based estimates available in the literature. An...
Full Text
Open DOI Link
Sign-in/Register to access full text options Topics from this Paper
Ankylosing Spondylitis- Standardized Prevalence Ratios
- General Population Cohort
- Use Of Non-steroidal Anti-inflammatory Agents
- Risk Of Comorbidity + Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population‐based study 
Relevant
Not Relevant
Arthritis & Rheumatism
Oct 28, 2011
RelevantNot Relevant Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study RelevantNot Relevant
- Arthritis Research & Therapy
- May 18, 2017
RelevantNot Relevant Estimating the Occurrence of Renal Complications Among Persons With Ankylosing Spondylitis RelevantNot Relevant
- Arthritis Care & Research
- Feb 24, 2014
RelevantNot Relevant Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Dec 19, 2017
RelevantNot Relevant Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis RelevantNot Relevant
- Arthritis Research & Therapy
- Jan 1, 2014
RelevantNot Relevant Midlife Ankylosing Spondylitis Increases the Risk of Cardiovascular Diseases in Males 5 Years Later RelevantNot Relevant
- Medicine
- May 1, 2016
RelevantNot Relevant Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand RelevantNot Relevant
- Journal of Medical Imaging and Radiation Oncology
- Feb 1, 2017
RelevantNot Relevant Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. RelevantNot Relevant
- Annals of Translational Medicine
- Mar 1, 2015
RelevantNot Relevant Erectile dysfunction in ankylosing spondylitis: a systematic review and meta-analysis RelevantNot Relevant
- Sexual Medicine
- Mar 1, 2023
RelevantNot Relevant Interleukin‐17 inhibitor, is it safer than tumor necrosis factor inhibitor? RelevantNot Relevant
- International Journal of Rheumatic Diseases
- Jul 1, 2021
RelevantNot Relevant All‐Cause and Cause‐Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta‐Analysis RelevantNot Relevant
- Arthritis Care & Research
- Jan 19, 2023
RelevantNot Relevant All-Cause and Cause-Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. RelevantNot Relevant
- Arthritis care & research
- Nov 17, 2021
RelevantNot Relevant Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers RelevantNot Relevant
- The Journal of Rheumatology
- Aug 15, 2011
RelevantNot Relevant Trends in hospitalizations for vertebral compression fracture in ankylosing spondylitis: data from the National Inpatient Sample 2000–2014 RelevantNot Relevant
- Clinical Rheumatology
- Jul 5, 2021
RelevantNot RelevantREAD MORE FROMAnnals of the Rheumatic Diseases
Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis 
Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 29, 2023
RelevantNot Relevant In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation Just PublishedRelevantNot Relevant
Just Published- Annals of the Rheumatic Diseases
- Nov 27, 2023
RelevantNot Relevant Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Nov 24, 2023
RelevantNot Relevant Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis 
Open AccessRelevantNot Relevant
Open Access- Annals of the Rheumatic Diseases
- Nov 24, 2023
RelevantNot Relevant 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases Open AccessRelevantNot Relevant
Open Access- Annals of the Rheumatic Diseases
- Nov 22, 2023
RelevantNot Relevant Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Nov 22, 2023
RelevantNot Relevant Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Tang et al Open AccessRelevantNot Relevant
Open Access- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant Response to: Correspondence on ‘ACR/EULAR antiphospholipid syndrome classification criteria’ by Damoiseaux and van Beers Open AccessRelevantNot Relevant
Open Access- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant Improving the nosology of Long COVID: it is not so simple RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant Response to: Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ by Miro-Mur et al Open AccessRelevantNot Relevant
Open Access- Annals of the Rheumatic Diseases
- Nov 21, 2023
RelevantNot Relevant